<DOC>
	<DOC>NCT02292433</DOC>
	<brief_summary>Study B1621018 will assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Dose Levels of Pf-04937319 in Japanese Subjects with Type 2 Diabetes Mellitus As Monotherapy</brief_summary>
	<brief_title>A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Patients with type 2 diabetes, on diet/exercise therapy only or background therapy with 1 oral antidiabetic agent (excluding Actos) Patients with cardiovascular event Patients with diabetic complications Female subjects who are pregnant or planning to become pregnant Subjects with unstable medical conditions (eg, hypertension)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>monotherapy</keyword>
	<keyword>PF-04937319</keyword>
</DOC>